iTIND for BPH: Technique and procedural outcomes: A narrative review of current literature

2021 ◽  
Vol 47 (6) ◽  
pp. 470-481
Author(s):  
Cristian Fiori ◽  
◽  
Sabrina De Cillis ◽  
Gabriele Volpi ◽  
Enrico Checcucci ◽  
...  
Author(s):  
Ratchana Rajendran ◽  
Bhagyalaxmi Singirikonda ◽  
Navpreet ◽  
Neetu Jain ◽  
Mohd Naved ◽  
...  

2012 ◽  
Vol 6 (2) ◽  
pp. 157-167 ◽  
Author(s):  
David S. Seres ◽  
Monika Valcarcel ◽  
Alexandra Guillaume

It is a strong and commonly held belief among nutrition clinicians that enteral nutrition is preferable to parenteral nutrition. We provide a narrative review of more recent studies and technical reviews comparing enteral nutrition with parenteral nutrition. Despite significant weaknesses in the existing data, current literature continues to support the use of enteral nutrition in patients requiring nutrition support, over parenteral nutrition.


2021 ◽  
Vol 5 (3) ◽  
pp. 23
Author(s):  
Jens Carsten Möller ◽  
Daniel Zutter ◽  
Robert Riener

This narrative review provides a brief overview of the current literature on technology-based interventions for the neurorehabilitation of persons with Parkinson’s disease (PD). The role of brain–computer interfaces, exergaming/virtual-reality-based exercises, robot-assisted therapies and wearables is discussed. It is expected that technology-based neurorehabilitation will gain importance in the management of PD patients, although it is often not clear yet whether this approach is superior to conventional therapies. High-intensity technology-based neurorehabilitation may hold promise with respect to neuroprotective or neurorestorative actions in PD. Overall, more research is required in order to obtain more data on the feasibility, efficacy and safety of technology-based neurorehabilitation in persons with PD.


2021 ◽  
Vol 0 ◽  
pp. 0-0
Author(s):  
Gianluca Perroni ◽  
Christopher Johnson ◽  
Sandeep Khandhar ◽  
Giulia Veronesi ◽  
Vincenzo Ambrogi ◽  
...  

2017 ◽  
Vol 2 (2) ◽  
pp. 152-156 ◽  
Author(s):  
Moumita Choudhury ◽  
Patricia Chavira

This review studies the current literature available on intervention approaches of auditory processing disorder (APDAPD intervention approaches should be based on specific deficits and customized to accommodate the needs of each patient. The discussion on the efficacy of various APD treatment approaches suggested that there is lack of evidence that short-term intervention improves auditory functioning. Increased understanding of the pathophysiologic bases of APD and systematic long-term research on APD interventions would fill the gaps in our knowledge and provide more definitive intervention recommendations.


2021 ◽  
Vol 9 (11) ◽  
pp. 955-955
Author(s):  
Till Markowiak ◽  
Christopher Larisch ◽  
Hans-Stefan Hofmann ◽  
Michael Ried

Author(s):  
Pietrzak JRT ◽  
Donaldson MJ ◽  
Kayani B ◽  
Rowan FE ◽  
Haddad FS

2021 ◽  
Vol 9 (2) ◽  
pp. 14-20
Author(s):  
Lisiane Freitas Leal ◽  
◽  
Daniel Marques Mota ◽  

Introduction:The thalidomide is probably the best-known teratogenic drug and still results in cases of severe physical deformities in children born in Brazil. Objective:To present the overall context of surveillance and pharmacovigilance of thalidomide in Brazil. Method:This article presents a narrative review of current literature concerning thalidomide regulation, policies, and pharmacovigilance in Brazil. Results:New cases of congenital abnormalities whose phenotype is compatible with thalidomide embryopathy were identified in the last ten years, while the approval of thalidomide for new indications was recently updated. The mechanisms of diagnosing thalidomide embryopathy are complex, remaining the challenge in distinguishing this condition from other congenital abnormalities. The increasing number of thalidomide users in Brazil is correlated with the occurrence of embryopathy and the real extension of the rationality of its use is largely unknown. Additionally, our pharmacovigilance and surveillance systems are predominantly based on voluntary reports, issues that remains over the years. Conclusions:The policies have improved over the years to prevent the fetus from being exposed to thalidomide, and current regulation establishes rules for controlling its distribution, prescription, dispensation, and use. Brazilian surveillance system is manual and pharmacovigilance is supported by voluntary reports. The failure of the system to properly control the thalidomide use and its effects might lead to serious consequences to the community; therefore, this subject deserves constant attention.


2018 ◽  
Vol 42 (5) ◽  
pp. 568 ◽  
Author(s):  
Rebekah Eden ◽  
Andrew Burton-Jones ◽  
Ian Scott ◽  
Andrew Staib ◽  
Clair Sullivan

Objective The transition to digital hospitals is fast-moving. Although US hospitals are further ahead than some others in implementing eHealth technologies, their early experiences are not necessarily generalisable to contemporary healthcare because both the systems and technologies have been rapidly evolving. It is important to provide up-to-date assessments of the evidence available. The aim of this paper is to provide an assessment of the current literature on the effects to be expected from hospital implementations of eHealth technologies. Methods A narrative review was conducted of systematic reviews investigating the effects of eHealth technologies (clinical decision support systems (CDSS), computerised provider order entry (CPOE), ePrescribing, electronic medical records (EMRs)) published between November 2015 and August 2017 and compared the findings with those of a previous narrative review that examined studies published between January 2010 and October 2015. The same search strategy and selection criteria were used in both studies. Results Of the seven relevant articles, three (42.9%) examined the effects of more than one eHealth system: only two (28.6%) studies were high quality, three (42.9%) were of intermediate quality and two (28.6%) were of low quality. We identified that EMRs are largely associated with conflicting findings. Previous reviews suggested that CPOE are associated with significant positive results of cost savings, organisational efficiency gains, less resource utilisation and improved individual performance. However, these effects were not investigated in the more recent reviews, and only mixed findings for communication between clinicians were reported. Similarly, for ePrescribing, later reviews reported limited evidence of benefits, although when coupled with CDSS, more consistent positive findings were reported. Conclusion This overview can help inform other hospitals in Australia and elsewhere of the likely effects resulting from eHealth technologies. The findings suggest that the effects of these systems are largely mixed, but there are positive findings, which encourage ongoing digital transformation of hospital practice. What is known about the topic? Governments are increasingly devoting substantial resources towards implementing eHealth technologies in hospital practice with the goals of improving clinical and financial outcomes. Yet, these outcomes are yet to be fully realised in practice and conflicting findings are often reported in the literature. What does this paper add? This paper extends a previous narrative review of systematic reviews and categorises the effects of eHealth technologies into a typology of outcomes to enable overall findings to be reported and comparisons to be made. In doings so, we synthesise 7 years of eHealth effects. Mixed results are largely reported for EMRs, with many benefits being compromised by practices stemming from resistance to EMRs. Limited evidence of effectiveness exists for CPOE and ePrescribing. CDSS are associated with the most consistent positive findings for clinician- and hospital-level effects. We observed renewed interest in the literature for the effect of eHealth technologies on communication both between clinicians and with patients. Other new insights have emerged relating to effects on clinical judgement, changing practice and staff retention. What are the implications for practitioners? eHealth technologies have the potential to positively affect clinical and financial outcomes. However, these benefits are not guaranteed, and mixed results are often reported. This highlights the need for hospitals and decision makers to clearly identify and act on the drivers of successful implementations if eHealth technologies are to facilitate the creation of new, more effective models of patient care in an increasingly complex healthcare environment.


Sign in / Sign up

Export Citation Format

Share Document